Company: NCEL
Filing Date: 2025-06-23
Form Type: F-4/A
Source: 0001213900-25-056787
Chunk: 5

Company: NewcelX Ltd.
Filing Date: 2025-06-23
Form: F-4/A
Chunk 5
---
 beneficial ownership limitation, at an exercise price equal to the par value of the NLS Common Shares as of the Effective Time, which, in any event, shall be no less than CHF 0.0001 per share. The Merger Agreement and the consummation of the transactions contemplated thereby have been approved by the NLS Board, and Kadimastem Board and shareholders, and the NLS Board has resolved, subject to customary exceptions, to recommend that the shareholders of the Company approve the Merger Agreement and the transactions contemplated therein. The NLS Common Shares and traded warrants are currently listed on the Nasdaq Capital Market (“Nasdaq”), under the symbols “NLSP” and “NLSPW”, respectively. NLS has filed an additional listing application with Nasdaq, as required by Nasdaq to effect the additional listing of NLS Common Shares issuable in connection with the Merger. NLS has applied to have the common shares of the surviving company trade on the Nasdaq after completion of the Merger, under NLS’s new name, NewcelX Ltd., and new trading symbols for its Common Shares and traded warrants, “NCEL” and “NCELW”, respectively. NLS is holding an extraordinary meeting of its shareholders, or the NLS Meeting, for the following purposes, as more fully described in the accompanying proxy statement: 1.To approve, on an advisory basis, the Merger Agreement. 2.To approve the increase of the share capital of the Company, by way of an ordinary capital increase, by up toOrdinary Shares, and up to a maximum of CHF, to create the required number of the NLS Common Shares to be issued at the effective time of the Merger to the shareholders of Kadimastem in exchange for their Kadimastem Ordinary Shares. 3.To approve the increase of the share capital of the Company, by way of an ordinary capital increase, by a maximum of CHF(i.e., via the issuance of a maximum offully paid -inpreferred shares in the Company (the “Preferred Shares”) with a nominal value of CHF 0.03 each). The NLS Board reserves the right to split the total maximum number offully paid -inPreferred Shares to one or more issuances of no less thanfully paid -inPreferred Shares per each increase. 4.To reinstate the capital band and to approve to amend the upper and the lower limit of the capital band in article 3a paragraph 1 of the Company’s articles